Financial Snapshot

Revenue
$8.719M
TTM
Gross Margin
94.21%
TTM
Net Earnings
-$20.11M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
248.13%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$64.79M
Q3 2024
Cash
Q3 2024
P/E
-5.722
Nov 29, 2024 EST
Free Cash Flow
-$23.06M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Revenue $8.945M $14.70M $4.341M $3.515M $4.988M $3.458M $5.923M $7.036M $5.243M $4.430M $3.920M $4.350M $3.680M $1.930M $1.500M $1.050M $1.160M $900.0K $690.0K $560.0K $390.0K $150.0K $50.00K $1.040M $250.0K $60.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -39.15% 238.63% -29.53% 44.25% -41.62% -15.82% 34.19% 18.36% 13.01% -9.89% 18.21% 90.67% 28.67% 42.86% -9.48% 28.89% 30.43% 23.21% 43.59% 160.0% 200.0% -95.19% 316.0% 316.67%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Revenue $8.945M $14.70M $4.341M $3.515M $4.988M $3.458M $5.923M $7.036M $5.243M $4.430M $3.920M $4.350M $3.680M $1.930M $1.500M $1.050M $1.160M $900.0K $690.0K $560.0K $390.0K $150.0K $50.00K $1.040M $250.0K $60.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $671.0K $728.0K $1.426M $385.0K $412.0K $302.0K $168.0K $358.0K $1.107M $837.1K $790.0K $430.0K $80.00K $30.00K
Gross Profit $8.274M $13.98M $2.915M $1.441M $3.103M $4.686M $3.290M $5.565M $5.929M $4.406M $3.640M $3.480M $4.350M $3.680M
Gross Profit Margin 92.5% 95.07% 67.15% 88.28% 93.95% 95.14% 93.96% 84.27% 84.04% 82.17% 88.78% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Selling, General & Admin $17.30M $22.51M $18.21M $15.57M $24.03M $24.73M $19.92M $28.43M $29.13M $17.56M $15.56M $10.37M $9.340M $5.640M $2.480M $2.620M $1.300M $1.490M $1.400M $1.480M $1.260M $1.320M $1.960M $1.780M $1.900M $710.0K $1.210M $950.0K $810.0K $930.0K $770.0K $410.0K $150.0K
YoY Change -23.13% 23.59% 16.96% -35.2% -2.81% 24.11% -29.92% -2.43% 65.95% 12.83% 50.05% 11.03% 65.6% 127.42% -5.34% 101.54% -12.75% 6.43% -5.41% 17.46% -4.55% -32.65% 10.11% -6.32% 167.61% -41.32% 27.37% 17.28% -12.9% 20.78% 87.8% 173.33% 0.0%
% of Gross Profit 209.11% 161.06% 624.77% 1080.57% 774.44% 527.66% 605.53% 510.8% 491.38% 398.45% 427.47% 297.99% 214.71% 153.26%
Research & Development $15.61M $13.99M $33.71M $11.12M $15.95M $18.76M $24.02M $36.11M $42.60M $37.53M $26.61M $18.12M $13.70M $7.890M $2.970M $1.710M $970.0K $1.420M $1.530M $1.120M $900.0K $1.100M $1.690M $3.360M $4.900M $1.720M $2.140M $1.140M $1.790M $780.0K $560.0K $380.0K $120.0K
YoY Change 11.57% -58.51% 203.27% -30.29% -14.97% -21.93% -33.46% -15.25% 13.51% 41.05% 46.85% 32.26% 73.64% 165.66% 73.68% 76.29% -31.69% -7.19% 36.61% 24.44% -18.18% -34.91% -49.7% -31.43% 184.88% -19.63% 87.72% -36.31% 129.49% 39.29% 47.37% 216.67% 0.0%
% of Gross Profit 188.6% 100.09% 1156.57% 771.48% 513.95% 400.23% 730.21% 648.81% 718.57% 851.82% 731.04% 520.69% 314.94% 214.4%
Depreciation & Amortization $692.0K $582.0K $873.0K $2.111M $3.129M $3.273M $3.296M $4.757M $6.334M $8.410M $3.960M $2.840M $2.360M $930.0K $30.00K $20.00K $0.00 $10.00K $10.00K $40.00K $50.00K $70.00K $60.00K $80.00K $60.00K $30.00K $40.00K $40.00K $30.00K $30.00K $10.00K $10.00K $10.00K
YoY Change 18.9% -33.33% -58.65% -32.53% -4.4% -0.7% -30.71% -24.9% -24.69% 112.38% 39.44% 20.34% 153.76% 3000.0% 50.0% -100.0% 0.0% -75.0% -20.0% -28.57% 16.67% -25.0% 33.33% 100.0% -25.0% 0.0% 33.33% 0.0% 200.0% 0.0% 0.0%
% of Gross Profit 8.36% 4.16% 29.95% 146.5% 100.84% 69.85% 100.18% 85.48% 106.83% 190.88% 108.79% 81.61% 54.25% 25.27%
Operating Expenses $33.01M $36.50M $52.13M $27.89M $41.98M $45.68M $43.95M $64.53M $71.74M $55.09M $42.17M $28.49M $23.04M $13.53M $5.450M $4.330M $2.270M $2.910M $2.920M $2.610M $2.160M $2.420M $3.650M $5.140M $6.800M $2.430M $3.350M $2.100M $2.600M $1.710M $1.340M $790.0K $260.0K
YoY Change -9.56% -29.99% 86.91% -33.57% -8.1% 3.95% -31.9% -10.04% 30.22% 30.63% 48.02% 23.65% 70.29% 148.26% 25.87% 90.75% -21.99% -0.34% 11.88% 20.83% -10.74% -33.7% -28.99% -24.41% 179.84% -27.46% 59.52% -19.23% 52.05% 27.61% 69.62% 203.85% 0.0%
Operating Profit -$24.73M -$22.52M -$49.21M -$26.45M -$38.88M -$41.00M -$40.66M -$58.97M -$65.81M -$50.68M -$38.53M -$25.01M -$18.69M -$9.850M
YoY Change 9.83% -54.24% 86.07% -31.97% -5.17% 0.83% -31.05% -10.4% 29.85% 31.54% 54.06% 33.81% 89.75%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Interest Expense $1.453M -$1.365M $3.727M $1.817M $16.50M -$82.53M -$54.73M $28.94M $3.319M $249.6K $130.0K $20.00K $30.00K -$2.270M -$1.650M -$970.0K -$230.0K -$160.0K -$80.00K -$1.150M -$1.090M -$830.0K -$280.0K $280.0K $180.0K $130.0K $220.0K $150.0K $120.0K $60.00K $0.00
YoY Change -206.45% -136.62% 105.12% -88.99% -119.99% 50.79% -289.11% 772.04% 1229.83% 91.98% 550.0% -33.33% -101.32% 37.58% 70.1% 321.74% 43.75% 100.0% -93.04% 5.5% 31.33% 196.43% 55.56% 38.46% -40.91% 46.67% 25.0% 100.0%
% of Operating Profit
Other Income/Expense, Net -$2.000K -$3.292M $1.691M $2.706M $3.143M -$1.315M $1.449M -$403.0K -$160.0K -$712.8K -$340.0K -$320.0K $220.0K -$70.00K $30.00K $10.00K $20.00K $40.00K $20.00K $30.00K $1.040M $20.00K $110.0K $170.0K $280.0K $90.00K $10.00K $0.00 $0.00 $10.00K $10.00K $20.00K $0.00
YoY Change -99.94% -294.68% -37.51% -13.9% -339.01% -190.75% -459.55% 151.88% -77.55% 109.64% 6.25% -245.45% -414.29% -333.33% 200.0% -50.0% -50.0% 100.0% -33.33% -97.12% 5100.0% -81.82% -35.29% -39.29% 211.11% 800.0% -100.0% 0.0% -50.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Pretax Income -$23.28M -$25.81M -$43.27M -$21.92M -$19.23M -$47.13M -$23.29M $18.62M -$62.65M -$51.15M -$56.19M -$25.31M -$18.44M -$12.19M -$5.140M -$3.780M -$1.440M -$1.870M -$2.080M -$3.040M -$1.660M -$2.840M -$3.660M -$4.930M -$5.480M -$2.090M -$3.090M -$1.970M -$2.380M -$1.550M -$1.210M -$710.0K -$260.0K
YoY Change -9.8% -40.35% 97.36% 13.99% -59.19% 102.37% -225.07% -129.72% 22.47% -8.96% 122.01% 37.26% 51.27% 137.16% 35.98% 162.5% -22.99% -10.1% -31.58% 83.13% -41.55% -22.4% -25.76% -10.04% 162.2% -32.36% 56.85% -17.23% 53.55% 28.1% 70.42% 173.08% 0.0%
Income Tax -$1.803M $500.0K -$1.239M -$7.407M -$346.0K $0.00 $0.00 -$4.516M -$7.376M -$3.280M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $50.00K $80.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$21.49M -$26.27M -$43.02M -$20.65M -$11.71M -$45.99M -$19.98M $33.57M -$46.99M -$36.41M -$43.88M -$21.43M -$16.52M -$11.18M -$5.140M -$3.780M -$1.440M -$1.870M -$2.080M -$3.090M -$1.740M -$2.840M -$3.660M -$4.930M -$5.480M -$2.090M -$3.090M -$1.970M -$2.380M -$1.550M -$1.210M -$710.0K -$260.0K
YoY Change -18.22% -38.93% 108.33% 76.35% -74.54% 130.23% -159.5% -171.44% 29.05% -17.02% 104.76% 29.72% 47.76% 117.51% 35.98% 162.5% -22.99% -10.1% -32.69% 77.59% -38.73% -22.4% -25.76% -10.04% 162.2% -32.36% 56.85% -17.23% 53.55% 28.1% 70.42% 173.08% 0.0%
Net Earnings / Revenue -240.2% -178.73% -990.99% -333.12% -922.01% -577.67% 566.81% -667.87% -694.45% -990.52% -546.68% -379.77% -303.8% -266.32% -252.0% -137.14% -161.21% -231.11% -447.83% -310.71% -728.21% -2440.0% -9860.0% -526.92% -836.0% -5150.0%
Basic Earnings Per Share -$0.12 -$0.15 -$0.26
Diluted Earnings Per Share -$0.12 -$0.15 -$261.5K -$137.6K -$80.46K -$362.4K -$174.5K $337.2K -$589.5K -$547.8K -$809.1K -$435.5K -$347.9K -$277.6K -$175.4K -$159.2K -$63.02K -$82.96K -$116.2K -$177.1K -$122.0K -$229.6K -$316.6K -$446.6K -$512.6K -$208.8K -$348.0K -$251.6K -$301.3K -$252.4K -$230.9K -$182.1K -$80.00K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Cash & Short-Term Investments $35.49M $57.88M $58.36M $41.56M $30.72M $30.74M $38.18M $22.72M $42.98M $29.49M $5.500M $4.300M $22.20M $33.30M $12.20M $0.00 $0.00 $600.0K $1.800M $1.400M $700.0K $1.300M $1.700M $1.300M $5.300M $2.400M $7.800M $2.400M $3.400M $5.700M $3.400M $3.400M
YoY Change -38.67% -0.83% 40.41% 35.31% -0.08% -19.47% 68.06% -47.15% 45.75% 436.18% 27.91% -80.63% -33.33% 172.95% -100.0% -66.67% 28.57% 100.0% -46.15% -23.53% 30.77% -75.47% 120.83% -69.23% 225.0% -29.41% -40.35% 67.65% 0.0%
Cash & Equivalents $35.44M $11.36M $55.74M $32.59M $9.497M $23.59M $36.84M $22.09M $42.23M $29.49M $5.500M $4.300M $22.20M $33.30M $12.20M $0.00 $0.00 $600.0K $1.800M $1.400M $700.0K $1.300M $1.700M $1.300M $5.300M $2.400M $7.800M $2.400M $3.400M $700.0K $1.500M $1.500M
Short-Term Investments $50.00K $46.52M $2.616M $8.977M $21.22M $7.154M $1.337M $627.0K $753.0K $3.000K $0.00 $5.000M $1.900M $1.900M
Other Short-Term Assets $2.204M $1.828M $2.351M $2.433M $2.863M $1.898M $1.402M $1.777M $2.609M $1.229M $1.200M $1.400M $1.700M $1.500M $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K $300.0K $100.0K $100.0K $100.0K $100.0K $200.0K $300.0K $200.0K $100.0K $100.0K $100.0K $100.0K
YoY Change 20.57% -22.25% -3.37% -15.02% 50.84% 35.38% -21.1% -31.89% 112.29% 2.42% -14.29% -17.65% 13.33% 1400.0% 0.0% 0.0% 0.0% 0.0% 0.0% -66.67% 200.0% 0.0% 0.0% 0.0% -50.0% -33.33% 50.0% 100.0% 0.0% 0.0% 0.0%
Inventory $1.000K $0.00 $200.0K $100.0K $100.0K $0.00 $0.00 $0.00 $100.0K $200.0K $0.00 $0.00 $0.00 $0.00
Prepaid Expenses
Receivables $745.0K $297.0K $50.84M $4.000K $44.00K $891.0K $139.0K $544.0K $1.321M $927.0K $1.100M $1.400M $400.0K $100.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $23.90M $2.828M $2.907M $613.0K $324.0K $493.0K $0.00 $0.00 $600.0K $600.0K
Total Short-Term Assets $38.44M $60.00M $111.5M $44.00M $57.52M $36.36M $42.62M $25.65M $47.24M $32.41M $7.900M $7.200M $25.00M $35.60M $12.40M $100.0K $100.0K $600.0K $1.900M $1.500M $1.000M $1.400M $1.800M $1.400M $5.400M $2.600M $8.200M $2.900M $3.500M $5.800M $3.500M $3.500M
YoY Change -35.93% -46.21% 153.53% -23.51% 58.2% -14.7% 66.18% -45.7% 45.77% 310.19% 9.72% -71.2% -29.78% 187.1% 12300.0% 0.0% -83.33% -68.42% 26.67% 50.0% -28.57% -22.22% 28.57% -74.07% 107.69% -68.29% 182.76% -17.14% -39.66% 65.71% 0.0%
Property, Plant & Equipment $4.767M $5.673M $4.872M $5.630M $8.175M $5.835M $5.533M $5.529M $7.539M $2.858M $3.000M $1.300M $1.300M $700.0K $100.0K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $200.0K $200.0K $300.0K $200.0K $100.0K $100.0K $100.0K $100.0K $100.0K $100.0K
YoY Change -15.97% 16.44% -13.46% -31.13% 40.1% 5.46% 0.07% -26.66% 163.79% -4.73% 130.77% 0.0% 85.71% 600.0% 0.0% -100.0% -50.0% 0.0% -33.33% 50.0% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $33.73M $117.2M $100.0M $4.671M $0.00
YoY Change -100.0% -71.21% 17.12% 2041.7%
Other Assets $577.0K $627.0K $630.0K $616.0K $864.0K $505.0K $1.018M $1.149M $1.621M $790.0K $600.0K $700.0K $900.0K $1.600M $900.0K $800.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -7.97% -0.48% 2.27% -28.7% 71.09% -50.39% -11.4% -29.12% 105.19% 31.67% -14.29% -22.22% -43.75% 77.78% 12.5% -100.0%
Total Long-Term Assets $62.58M $63.66M $63.00M $63.95M $67.96M $65.30M $130.6M $116.9M $47.42M $42.50M $49.80M $22.50M $20.80M $17.70M $1.000M $900.0K $100.0K $100.0K $100.0K $0.00 $100.0K $100.0K $100.0K $300.0K $300.0K $200.0K $100.0K $100.0K $100.0K $100.0K $0.00 $0.00
YoY Change -1.71% 1.06% -1.49% -5.9% 4.07% -50.01% 11.71% 146.55% 11.59% -14.67% 121.33% 8.17% 17.51% 1670.0% 11.11% 800.0% 0.0% 0.0% -100.0% 0.0% 0.0% -66.67% 0.0% 50.0% 100.0% 0.0% 0.0% 0.0%
Total Assets $101.0M $123.7M $174.5M $107.9M $125.5M $101.7M $173.2M $142.6M $94.66M $74.90M $57.70M $29.70M $45.80M $53.30M $13.40M $1.000M $200.0K $700.0K $2.000M $1.500M $1.100M $1.500M $1.900M $1.700M $5.700M $2.800M $8.300M $3.000M $3.600M $5.900M $3.500M $3.500M
YoY Change
Accounts Payable $2.050M $2.393M $3.543M $2.611M $2.427M $2.359M $938.0K $1.593M $2.798M $2.297M $3.900M $1.200M $1.100M $1.000M $500.0K $1.200M $500.0K $400.0K $600.0K $300.0K $400.0K $400.0K $200.0K $400.0K $600.0K $200.0K $200.0K $100.0K $300.0K $0.00 $0.00 $0.00
YoY Change -14.33% -32.46% 35.7% 7.58% 2.88% 151.49% -41.12% -43.07% 21.81% -41.1% 225.0% 9.09% 10.0% 100.0% -58.33% 140.0% 25.0% -33.33% 100.0% -25.0% 0.0% 100.0% -50.0% -33.33% 200.0% 0.0% 100.0% -66.67%
Accrued Expenses $5.050M $7.131M $25.05M $4.416M $3.985M $4.332M $4.855M $5.318M $6.185M $4.147M $600.0K $500.0K $600.0K $400.0K $0.00 $100.0K $100.0K $100.0K
YoY Change -29.18% -71.53% 467.23% 10.82% -8.01% -10.77% -8.71% -14.02% 49.14% 591.17% 20.0% -16.67% 50.0% -100.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $523.0K $0.00 $0.00 $0.00 $833.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.900M $700.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0% 171.43%
Long-Term Debt Due $52.00K $36.00K $30.00K $16.00K $33.00K $70.00K $152.0K $99.00K $95.00K $0.00 $0.00 $2.700M
YoY Change 44.44% 20.0% 87.5% -51.52% -52.86% -53.95% 53.54% 4.21% -100.0%
Total Short-Term Liabilities $17.96M $18.98M $47.12M $7.769M $6.494M $6.812M $6.879M $8.850M $12.46M $7.069M $7.000M $4.400M $3.100M $2.500M $1.200M $3.400M $1.500M $600.0K $700.0K $300.0K $3.100M $500.0K $300.0K $400.0K $600.0K $400.0K $1.300M $100.0K $300.0K $0.00 $0.00 $0.00
YoY Change -5.38% -59.71% 506.46% 19.63% -4.67% -0.97% -22.27% -28.98% 76.29% 0.99% 59.09% 41.94% 24.0% 108.33% -64.71% 126.67% 150.0% -14.29% 133.33% -90.32% 520.0% 66.67% -25.0% -33.33% 50.0% -69.23% 1200.0% -66.67%
Long-Term Debt $91.00K $84.00K $30.00K $26.00K $77.00K $1.958M $1.169M $2.848M $4.970M $469.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.200M $1.700M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 8.33% 180.0% 15.38% -66.23% -96.07% 67.49% -58.95% -42.7% 959.7% -100.0% 29.41%
Other Long-Term Liabilities $20.67M $30.59M $34.43M $2.951M $4.345M $644.0K $930.0K $366.0K $781.0K $125.0K $200.0K $1.100M $1.200M $1.400M $1.200M $2.000M $1.800M $1.900M $1.400M $900.0K $400.0K $400.0K $0.00 $100.0K $100.0K $100.0K $100.0K
YoY Change -32.42% -11.15% 1066.55% -32.08% 574.69% -30.75% 154.1% -53.14% 524.8% -37.5% -81.82% -8.33% -14.29% 16.67% -40.0% 11.11% -5.26% 35.71% 55.56% 125.0% -100.0% 0.0% 0.0% 0.0%
Total Long-Term Liabilities $20.76M $30.67M $34.46M $2.977M $4.422M $2.602M $2.099M $3.214M $5.751M $594.0K $200.0K $1.100M $1.200M $1.400M $1.200M $2.000M $1.800M $1.900M $1.400M $900.0K $400.0K $2.200M $1.700M $0.00 $0.00 $0.00 $400.0K $0.00 $100.0K $100.0K $100.0K $100.0K
YoY Change -32.3% -10.98% 1057.37% -32.68% 69.95% 23.96% -34.69% -44.11% 868.18% 197.0% -81.82% -8.33% -14.29% 16.67% -40.0% 11.11% -5.26% 35.71% 55.56% 125.0% -81.82% 29.41% -100.0% -100.0% 0.0% 0.0% 0.0%
Total Liabilities $37.60M $50.33M $82.32M $11.75M $12.52M $7.820M $10.60M $24.64M $67.77M $38.45M $42.90M $20.20M $17.20M $15.10M $6.400M $5.400M $3.200M $2.500M $2.200M $1.200M $3.500M $2.700M $2.000M $400.0K $600.0K $400.0K $1.800M $100.0K $400.0K $100.0K $100.0K $100.0K
YoY Change -25.29% -38.87% 600.63% -6.14% 60.09% -26.23% -56.99% -63.64% 76.28% -10.38% 112.38% 17.44% 13.91% 135.94% 18.52% 68.75% 28.0% 13.64% 83.33% -65.71% 29.63% 35.0% 400.0% -33.33% 50.0% -77.78% 1700.0% -75.0% 300.0% 0.0% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991
Basic Shares Outstanding 172.7M 169.8M shares 164.5M shares
Diluted Shares Outstanding 172.7M 169.8M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $115.08 Million

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company is headquartered in Carlsbad, California and currently employs 75 full-time employees. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment epithelial cell therapy in phase II a development, for the treatment of geographic atrophy secondary to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in phase I/II a development for the treatment of spinal cord injuries; ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and RND1.

Industry: Biological Products, (No Diagnostic Substances) Peers: FENNEC PHARMACEUTICALS INC. Clene Inc. Compass Therapeutics, Inc. Gritstone bio, Inc. Kronos Bio, Inc. MACROGENICS INC Shuttle Pharmaceuticals Holdings, Inc. Viking Therapeutics, Inc. XOMA Royalty Corp